PRESS RELEASE published on 05/02/2025 at 17:45, 1 year 4 months ago Affluent Medical : Mise à disposition du Document d’Enregistrement Universel (DEU) 2024. Affluent Medical annonce la mise à disposition de son Document d'Enregistrement Universel (DEU) 2024 pour consultation publique. Ce document inclut le rapport financier annuel, les rapports des commissaires aux comptes et le descriptif du programme de rachat d'actions Affluent Medical Prothèses Médicales MedTech Document D'Enregistrement Universel DEU 2024
BRIEF published on 04/24/2025 at 17:50, 1 year 5 months ago Affluent Medical concrétise des avancées majeures en 2024 Innovation Médicale Affluent Medical Développement Clinique Cardiologie Accords Stratégiques
BRIEF published on 04/24/2025 at 17:50, 1 year 5 months ago Affluent Medical achieves major progress in 2024 Clinical Development Affluent Medical Cardiology Medical Innovation Strategic Agreements
PRESS RELEASE published on 04/24/2025 at 17:45, 1 year 5 months ago Affluent Medical : RESULTATS ANNUELS 2024 : Affluent Medical franchit de nouveaux jalons clés dans l’exécution de sa feuille de route clinique Affluent Medical franchit de nouveaux jalons clés dans l’exécution de sa feuille de route clinique en 2024, avec des accords stratégiques et des avancées réglementaires majeures Résultats Annuels Affluent Medical Accords Stratégiques Technologies Médicales Feuille De Route Clinique
PRESS RELEASE published on 04/24/2025 at 17:45, 1 year 5 months ago Affluent Medical : 2024 FULL YEAR RESULTS Affluent Medical reached major new milestones in executing its clinical roadmap Affluent Medical reached major new milestones in executing its clinical roadmap in 2024, including transformative agreements and positive FDA feedback. Financial results show progress and strategic appointments Financial Results Affluent Medical FDA Feedback Milestones 2024 Full Year Results
PRESS RELEASE published on 04/24/2025 at 17:45, 1 year 5 months ago 2024 FULL YEAR RESULTS Affluent Medical reached major new milestones in executing its clinical roadmap Affluent Medical announces major milestones in its 2024 full-year results including transformative agreements, regulatory validations, and clinical advancements, positioning the company for market launch Medical Technology Affluent Medical Clinical Advancements Market Launch 2024 Full-year Results
BRIEF published on 04/15/2025 at 17:50, 1 year 5 months ago Affluent Medical Advances Towards SPHINX Study for Female SUI Treatment Affluent Medical Artus Device SPHINX Study Female Stress Incontinence Minimally Invasive
BRIEF published on 04/15/2025 at 17:50, 1 year 5 months ago Des avancées médicales prometteuses vers l'étude SPHINX pour le traitement de l'incontinence urinaire à l'effort (IUE) chez la femme Médical Aisé Appareil Artus Étude SPHINX Incontinence D'effort Féminine Minimalement Invasif
PRESS RELEASE published on 04/15/2025 at 17:45, 1 year 5 months ago Affluent Medical Announces Progress Toward European Clinical Study of Artificial Sphincter Artus for the Treatment of Urinary Stress Incontinence in Women. Affluent Medical progresses towards European clinical study of Artificial Sphincter Artus for treating Urinary Stress Incontinence in Women. The upcoming SPHINX study will assess device safety and performance Affluent Medical Women European Clinical Study Artificial Sphincter Artus Urinary Stress Incontinence
PRESS RELEASE published on 04/15/2025 at 17:45, 1 year 5 months ago Affluent Medical progresse vers une étude clinique européenne sur le sphincter artificiel Artus pour le traitement de l'incontinence urinaire d'effort chez la femme. Affluent Medical progresse vers une étude clinique européenne sur le sphincter artificiel Artus pour le traitement de l'incontinence urinaire d'effort chez la femme Affluent Medical Étude Clinique Sphincter Artificiel Artus Incontinence Urinaire D'effort Femme
Published on 09/28/2026 at 23:00, 56 minutes ago CORRECTION FROM SOURCE: Organto Foods Highlights Record First Half Results and Progress on Key Strategic Initiatives
Published on 09/28/2026 at 15:00, 8 hours 56 minutes ago Vox to Acquire Silver Royalty over the Sorby Hills Project in Australia
Published on 09/28/2026 at 14:45, 9 hours 11 minutes ago Clinical Trial of the Oral Drug NV-387 to Treat Ebola Has Started Enrollment and Dosing of Patients Last Week (on or about September 23rd), Says NanoViricides
Published on 09/28/2026 at 14:30, 9 hours 26 minutes ago Drilling at Cat Creek Intersects a Copper-Molybdenum Porphyry System Visible Molybdenite-Chalcopyrite Over Significant Core Widths
Published on 09/28/2026 at 14:30, 9 hours 26 minutes ago Predictiv AI Completes United Nations Fleet Management Deployment Following Competitive Procurement Win
Published on 09/28/2026 at 22:14, 1 hour 42 minutes ago EQS-Adhoc: Extension of the Managing Directors' employment contracts of Carsten Cramer, Lars Ricken and Thomas Treß – Carsten Cramer appointed Chairman of the Management Board
Published on 09/28/2026 at 19:24, 4 hours 31 minutes ago EQS-Adhoc: Hapag-Lloyd further raises its earnings outlook for the current financial year
Published on 09/28/2026 at 19:00, 4 hours 56 minutes ago PATRIMOINE ET COMMERCE : Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 21 septembre 2026 au 25 septembre 2026
Published on 09/28/2026 at 18:00, 5 hours 56 minutes ago GEVELOT S.A.: Weekly declaration of share buybacks – 09/28/2026 (French only)
Published on 09/28/2026 at 18:00, 5 hours 56 minutes ago GEVELOT S.A.: Déclaration hebdomadaire de rachat d'actions 28/09/2026
Published on 09/28/2026 at 17:54, 6 hours 1 minute ago Reporting on share buyback transactions carried out between September 21 and September 25, 2026
Published on 09/28/2026 at 17:54, 6 hours 1 minute ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 21 et le 25 septembre 2026
Published on 09/28/2026 at 17:45, 6 hours 11 minutes ago Déclaration hebdomadaire de rachat d'actions
Published on 09/28/2026 at 17:35, 6 hours 21 minutes ago Déclaration hebdomadaire d'opérations effectuées du 21 au 25 septembre 2026